AI for Health 2026
															Bochum, Germany
11-13 March 2026
Develop your investments, innovation and outlook in AI for Health
Immerse yourself in a dynamic environment dedicated to advancing AI-driven healthcare solutions:
Event Highlights
Selected Companies
Seasoned investors
One2One Meetings
Tech Tracks
															Drug Discovery
- Drug & Digital therapeutics
 - Biomarkers
 - Digital clinical trials
 - Personalised medicine
 
															Prevention
- Diagnostics & imaging
 - AI for consultation
 - Genomic, clinical, personal, activity, data, cross-analysis
 - Predictive modelling
 
															Virtual Care
- AI for point of care
 - Transcribe & retrieve
 - Servicing care & claims
 - Accelerated analysis
 - Data security and trust
 
Explore Further
Hear from our Participants
See why industry leaders keep coming back year after year
											
											
											Join the Journey
Kindly contact Maria Georgieva at maria@techtour.com to receive more information.
*For media representatives, please fill out this registration form to request a media pass for the event
Registration Fee
General Pass
- Full аccess to the whole program on March 11-13
 - Networking opportunities with 100+ participants;
 - Opportunities to schedule One2One meetings with other participants;
 - Exciting discussions about the current and future trends in Health and AI led by esteemed industry experts;
 - Access to the event app;
 - All inclusive catering.
 
A 30% early bird discount is automatically applied, reducing your ticket price to €693 until 1 December 2025
€990 *
* All prices excl VAT
** View Cancellations and No-Show policy
Timeline
- 
                    
Company application period
1 November - 19 December 2025
 - 
                    
Company selection announced
2 February 2026
 - 
                    
Selected companies meeting
5 February 2026
 - 
                    
Online Academy
10-11 February 2026
 - 
                    
Event in Bochum
11-13 March 2026
 
Related News
Newsletter
Stay up to date with market insights, trailblazing investment cases, and leadership profiles by subscribing to our newsletter.